Benchmarking post-GWAS analysis tools in major depression: Challenges and implications

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Pérez-Granado, Judith
• dc.contributor.author Piñero González, Janet, 1977-
• dc.contributor.author Furlong, Laura I., 1971-
• dc.date.accessioned 2023-03-02T07:05:32Z
• dc.date.available 2023-03-02T07:05:32Z
• dc.date.issued 2022
• dc.description.abstract Our knowledge of complex disorders has increased in the last years thanks to the identification of genetic variants (GVs) significantly associated with disease phenotypes by genome-wide association studies (GWAS). However, we do not understand yet how these GVs functionally impact disease pathogenesis or their underlying biological mechanisms. Among the multiple post-GWAS methods available, fine-mapping and colocalization approaches are commonly used to identify causal GVs, meaning those with a biological effect on the trait, and their functional effects. Despite the variety of post-GWAS tools available, there is no guideline for method eligibility or validity, even though these methods work under different assumptions when accounting for linkage disequilibrium and integrating molecular annotation data. Moreover, there is no benchmarking of the available tools. In this context, we have applied two different fine-mapping and colocalization methods to the same GWAS on major depression (MD) and expression quantitative trait loci (eQTL) datasets. Our goal is to perform a systematic comparison of the results obtained by the different tools. To that end, we have evaluated their results at different levels: fine-mapped and colocalizing GVs, their target genes and tissue specificity according to gene expression information, as well as the biological processes in which they are involved. Our findings highlight the importance of fine-mapping as a key step for subsequent analysis. Notably, the colocalizing variants, altered genes and targeted tissues differed between methods, even regarding their biological implications. This contribution illustrates an important issue in post-GWAS analysis with relevant consequences on the use of GWAS results for elucidation of disease pathobiology, drug target prioritization and biomarker discovery.
• dc.description.sponsorship IMI2-JU resources which are composed of financial contributions from the European Union’s Horizon 2020 Research and Innovation Programme and EFPIA (GA: 116030 TransQST and GA: 777365 eTRANSAFE), and the EU H2020 Programme 2014–2020 (GA: 676559 Elixir-Excelerate); Project 001-P-001647—Valorisation of EGA for Industry and Society funded by the European Regional Development Fund (ERDF) and Generalitat de Catalunya; Agència de Gestió d’Ajuts Universitaris i de Recerca Generalitat de Catalunya (2017SGR00519), and the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, “A way to make Europe”). The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), funded by ISCIII and ERDF (PRB2-ISCIII (PT13/0001/0023, of the PE I + D + i 2013–2016)). The MELIS is a ‘Unidad de Excelencia María de Maeztu’, funded by the MINECO (MDM-2014-0370). JP-G was supported by Instituto de Salud Carlos III-Fondo Social Europeo (FI18/00034). This statement is a requirement from our funding agencies and therefore has to be included in the Funding section.
• dc.format.mimetype application/pdf
• dc.identifier.citation Pérez-Granado J, Piñero J, Furlong LI. Benchmarking post-GWAS analysis tools in major depression: Challenges and implications. Front Genet. 2022 Oct 5;13:1006903. DOI: 10.3389/fgene.2022.1006903
• dc.identifier.doi http://dx.doi.org/10.3389/fgene.2022.1006903
• dc.identifier.issn 1664-8021
• dc.identifier.uri http://hdl.handle.net/10230/56007
• dc.language.iso eng
• dc.publisher Frontiers
• dc.relation.ispartof Front Genet. 2022 Oct 5;13:1006903
• dc.relation.projectID info:eu-repo/grantAgreement/EC/H2020/116030
• dc.relation.projectID info:eu-repo/grantAgreement/EC/H2020/777365
• dc.relation.projectID info:eu-repo/grantAgreement/EC/H2020/676559
• dc.rights © 2022 Pérez-Granado, Piñero and Furlong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by/4.0/
• dc.subject.keyword Colocalization
• dc.subject.keyword eQTLs
• dc.subject.keyword Fine-mapping
• dc.subject.keyword Major depression
• dc.subject.keyword Post-GWAS
• dc.title Benchmarking post-GWAS analysis tools in major depression: Challenges and implications
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion